Daiwa Securities Group
ALT icon

Daiwa Securities Group’s Altimmune ALT Stock Holding History

Daiwa Securities Group’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-235
Closed -$1K – 1192
2025
Q4 		$1K Hold
235
– – ﹤0.01% 1336
2025
Q3 		$1K Hold
235
– – ﹤0.01% 1295
2025
Q2 		$1K Hold
235
– – ﹤0.01% 1243
2025
Q1 		$1K Hold
235
– – ﹤0.01% 1208
2024
Q4 		$2K Buy
+235
New +$1.79K ﹤0.01% 1208
2023
Q4 		– Sell
-136
Closed – – 1327
2023
Q3 		$0 Hold
136
– – ﹤0.01% 1290
2023
Q2 		$0 Hold
136
– – ﹤0.01% 1321
2023
Q1 		$1K Hold
136
– – ﹤0.01% 1238
2022
Q4 		$2K Hold
136
– – ﹤0.01% 1208
2022
Q3 		$2K Hold
136
– – ﹤0.01% 1215
2022
Q2 		$2K Hold
136
– – ﹤0.01% 1218
2022
Q1 		$1K Hold
136
– – ﹤0.01% 1290
2021
Q4 		$1K Hold
136
– – ﹤0.01% 1324
2021
Q3 		$2K Buy
136
+74
+119% +$900 ﹤0.01% 1236
2021
Q2 		$1K Hold
62
– – ﹤0.01% 1177
2021
Q1 		$1K Hold
62
– – ﹤0.01% 1183
2020
Q4 		$1K Buy
+62
New +$731 ﹤0.01% 1160

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Daiwa Securities Group's ALT Position: Q1 2026 in Review

Daiwa Securities Group sold out of Altimmune (ALT) in Q1 2026, closing a stake of 235 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in ALT in Q4 2020 and held it in 17 quarters. The position peaked at $2K in Q4 2024. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Daiwa Securities Group reported no remaining Altimmune position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 235 Altimmune shares in Q1 2026, an estimated $1K.
  • Daiwa Securities Group first reported a position in Altimmune in Q4 2020 and held it in 17 quarters.
  • Daiwa Securities Group's Altimmune position peaked at $2K in Q4 2024.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.